100 related articles for article (PubMed ID: 21778941)
21. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS
Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
[TBL] [Abstract][Full Text] [Related]
23. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
Miyanaga T; Hirato J; Nakazato Y
Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA as potential biomarkers in Glioblastoma.
Areeb Z; Stylli SS; Koldej R; Ritchie DS; Siegal T; Morokoff AP; Kaye AH; Luwor RB
J Neurooncol; 2015 Nov; 125(2):237-48. PubMed ID: 26391593
[TBL] [Abstract][Full Text] [Related]
25. PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation.
Fiano V; Ghimenti C; Imarisio S; Silengo L; Schiffer D
Anticancer Res; 2004; 24(5A):2643-7. PubMed ID: 15517868
[TBL] [Abstract][Full Text] [Related]
26. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
27. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
28. Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.
Brown RE; Law A
Ann Clin Lab Sci; 2006; 36(4):421-6. PubMed ID: 17127728
[TBL] [Abstract][Full Text] [Related]
29. High level EGFR amplification in a newly established glioblastoma cell line 170-MG-BA.
MacLeod RAF; Schneider B; Sivakova I; Nagel S; Dirks WG; Mraz P; Kubikova E; Perzelova A
Neoplasma; 2019 Jan; 66(1):109-117. PubMed ID: 30509096
[TBL] [Abstract][Full Text] [Related]
30. Genetic pathways to glioblastoma: a population-based study.
Ohgaki H; Dessen P; Jourde B; Horstmann S; Nishikawa T; Di Patre PL; Burkhard C; Schüler D; Probst-Hensch NM; Maiorka PC; Baeza N; Pisani P; Yonekawa Y; Yasargil MG; Lütolf UM; Kleihues P
Cancer Res; 2004 Oct; 64(19):6892-9. PubMed ID: 15466178
[TBL] [Abstract][Full Text] [Related]
31. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
[TBL] [Abstract][Full Text] [Related]
32. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
[TBL] [Abstract][Full Text] [Related]
33. [Abnormalities of the EGF receptor gene in brain tumors].
Shibuya M
No To Shinkei; 1998 Jun; 50(6):519-27. PubMed ID: 9656247
[No Abstract] [Full Text] [Related]
34. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
35. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
37. Mutations of NFKBIA in biopsy specimens from Hodgkin lymphoma.
Liu X; Yu H; Yang W; Zhou X; Lu H; Shi D
Cancer Genet Cytogenet; 2010 Mar; 197(2):152-7. PubMed ID: 20193848
[TBL] [Abstract][Full Text] [Related]
38. Gene amplification and splice variants of 25-hydroxyvitamin D3 1,alpha-hydroxylase (CYP27B1) in glioblastoma multiforme--a possible role in tumor progression?
Diesel B; Fischer U; Meese E
Recent Results Cancer Res; 2003; 164():151-5. PubMed ID: 12899520
[TBL] [Abstract][Full Text] [Related]
39. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.
Stevenson CB; Ehtesham M; McMillan KM; Valadez JG; Edgeworth ML; Price RR; Abel TW; Mapara KY; Thompson RC
Neurosurgery; 2008 Sep; 63(3):560-9; discussion 569-70. PubMed ID: 18812968
[TBL] [Abstract][Full Text] [Related]
40. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status.
Navarro L; Gil-Benso R; Megías J; Muñoz-Hidalgo L; San-Miguel T; Callaghan RC; González-Darder JM; López-Ginés C; Cerdá-Nicolás MJ
Neuroscience; 2015 Jun; 297():243-51. PubMed ID: 25869624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]